Dina JD - EQRx Gen Sec

EQRXDelisted Stock  USD 1.83  0.13  6.63%   

Insider

Dina JD is Gen Sec of EQRx Inc
Age 54
Phone617 315 2255
Webhttps://www.eqrx.com

EQRx Management Efficiency

The company has return on total asset (ROA) of (0.1379) % which means that it has lost $0.1379 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2025) %, meaning that it created substantial loss on money invested by shareholders. EQRx's management efficiency ratios could be used to measure how well EQRx manages its routine affairs as well as how well it operates its assets and liabilities.
EQRx Inc currently holds 3.83 M in liabilities with Debt to Equity (D/E) ratio of 0.0, which may suggest the company is not taking enough advantage from borrowing. EQRx Inc has a current ratio of 28.18, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about EQRx's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Kevan ShokatRevolution Medicines
N/A
Mark MurckoRelay Therapeutics
64
Osvaldo FloresCentury Therapeutics
61
Isabel AznarezStoke Therapeutics
52
Jennifer LacheyKeros Therapeutics
51
Jenna CohenBlueprint Medicines Corp
N/A
Kristina ZambourasC4 Therapeutics
N/A
Simon MBBSKeros Therapeutics
54
Bill DeGradoPliant Therapeutics
N/A
Charles NewtonLyell Immunopharma
53
Chandra LovejoyErasca Inc
53
Melanie MorrisonBlack Diamond Therapeutics
49
Nello MDKymera Therapeutics
45
Lisa TesvichBonoraErasca Inc
N/A
Elaine CaugheyKymera Therapeutics
N/A
Gregory RussottiCentury Therapeutics
57
Christopher RobertsBlack Diamond Therapeutics
54
Prof MDLyell Immunopharma
N/A
CPA MSErasca Inc
55
Nathanael GrayC4 Therapeutics
N/A
Sunil MDSana Biotechnology
54
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts. Eqrx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 240 people. EQRx Inc (EQRX) is traded on NASDAQ Exchange in USA and employs 362 people.

Management Performance

EQRx Inc Leadership Team

Elected by the shareholders, the EQRx's board of directors comprises two types of representatives: EQRx inside directors who are chosen from within the company, and outside directors, selected externally and held independent of EQRx. The board's role is to monitor EQRx's management team and ensure that shareholders' interests are well served. EQRx's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, EQRx's outside directors are responsible for providing unbiased perspectives on the board's policies.
Daniel Hoey, Chief Operations
Robert LLB, CoFounder Advisor
Alexis AM, Founder Directors
MAPP MD, CoFounder Advisor
Jamilu Rubin, Chief Officer
Sir CBE, CoFounder Advisor
Rona Anhalt, Chief Officer
Eric MD, Chief Exec
Melanie Nallicheri, CEO Director
Dina JD, Gen Sec

EQRx Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is EQRx a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Consideration for investing in EQRx Stock

If you are still planning to invest in EQRx Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the EQRx's history and understand the potential risks before investing.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
CEOs Directory
Screen CEOs from public companies around the world
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios